These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18716861)

  • 61. High Thymic Output of Effector CD4
    Zhao Y; Alard P; Kosiewicz MM
    J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apoptotic non-beta cells suppress beta cell antigen-reactive T cells and induce beta cell antigen-specific regulatory T cells.
    Xia CQ; Qiu Y; Peng R; Lo-Dauer J; Clare-Salzler MJ
    Ann N Y Acad Sci; 2008 Dec; 1150():167-70. PubMed ID: 19120288
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes.
    Hope CM; Welch J; Mohandas A; Pederson S; Hill D; Gundsambuu B; Eastaff-Leung N; Grosse R; Bresatz S; Ang G; Papademetrios M; Zola H; Duhen T; Campbell D; Brown CY; Krumbiegel D; Sadlon T; Couper JJ; Barry SC
    Eur J Immunol; 2019 Aug; 49(8):1235-1250. PubMed ID: 31127857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
    Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
    Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.
    Vaitaitis GM; Waid DM; Yussman MG; Wagner DH
    Immunology; 2017 Oct; 152(2):243-254. PubMed ID: 28542921
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
    Azzi J; Thueson L; Moore R; Abdoli R; Reijonen H; Abdi R
    PLoS One; 2017; 12(1):e0169695. PubMed ID: 28081180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
    Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
    PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
    Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
    J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.
    Bluestone JA; Tang Q
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14622-6. PubMed ID: 15322272
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.
    Tang Q; Adams JY; Penaranda C; Melli K; Piaggio E; Sgouroudis E; Piccirillo CA; Salomon BL; Bluestone JA
    Immunity; 2008 May; 28(5):687-97. PubMed ID: 18468463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.
    Wang N; Rajasekaran N; Hou T; Macaubas C; Mellins ED
    PLoS One; 2015; 10(5):e0128494. PubMed ID: 26020954
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
    Tonkin DR; He J; Barbour G; Haskins K
    J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
    Lu J; Liang Y; Zhao J; Meng H; Zhang X
    Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
    Kornete M; Piccirillo CA
    Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
    Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP
    J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21.
    Clough LE; Wang CJ; Schmidt EM; Booth G; Hou TZ; Ryan GA; Walker LS
    J Immunol; 2008 Apr; 180(8):5393-401. PubMed ID: 18390721
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
    Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
    Front Immunol; 2021; 12():635767. PubMed ID: 33815387
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse.
    Bour-Jordan H; Salomon BL; Thompson HL; Santos R; Abbas AK; Bluestone JA
    J Immunol; 2007 Jul; 179(2):1004-12. PubMed ID: 17617592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.